BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18814280)

  • 21. CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
    Pei KL; Yuan Y; Qin SH; Wang Y; Zhou L; Zhang HL; Qu XJ; Cui SX
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):1029-38. PubMed ID: 22186885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-mast cell interactions: induction of pro-tumorigenic genes and anti-tumorigenic 4-1BB in MCs in response to Lewis Lung Carcinoma.
    Wensman H; Kamgari N; Johansson A; Grujic M; Calounova G; Lundequist A; Rönnberg E; Pejler G
    Mol Immunol; 2012 Apr; 50(4):210-9. PubMed ID: 22343053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-17 potently increases non-small cell lung cancer growth.
    Wei L; Wang H; Yang F; Ding Q; Zhao J
    Mol Med Rep; 2016 Feb; 13(2):1673-80. PubMed ID: 26708832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asian ginseng extract inhibits in vitro and in vivo growth of mouse lewis lung carcinoma via modulation of ERK-p53 and NF-κB signaling.
    Wong VK; Cheung SS; Li T; Jiang ZH; Wang JR; Dong H; Yi XQ; Zhou H; Liu L
    J Cell Biochem; 2010 Nov; 111(4):899-910. PubMed ID: 20665661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal anti-double-stranded DNA antibodies cross-react with phosphoglycerate kinase 1 and inhibit the expression and production of IL-2 in activated Jurkat T cell line.
    Luan HY; Tang SJ; Yang W; Tsai CY; Sun GH; Sun KH
    Clin Immunol; 2006 Sep; 120(3):326-34. PubMed ID: 16857429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NK cell depletion results in accelerated tumor growth and attenuates the antitumor effect of total body irradiation.
    Miller GM; Andres ML; Gridley DS
    Int J Oncol; 2003 Dec; 23(6):1585-92. PubMed ID: 14612930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.
    Zhang Y; Liu Q; Zhang M; Yu Y; Liu X; Cao X
    J Immunol; 2009 Mar; 182(6):3801-8. PubMed ID: 19265159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2.
    Mulligan JK; Rosenzweig SA; Young MR
    J Immunother; 2010; 33(2):126-35. PubMed ID: 20145550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
    Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.
    Garrido G; Rabasa A; Garrido C; López A; Chao L; García-Lora AM; Garrido F; Fernández LE; Sánchez B
    Oncogene; 2014 Jun; 33(24):3129-39. PubMed ID: 23975426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape.
    Chen C; Qu QX; Shen Y; Mu CY; Zhu YB; Zhang XG; Huang JA
    Cancer Lett; 2012 Apr; 317(1):99-105. PubMed ID: 22108530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leucine-rich α-2-glycoprotein promotes TGFβ1-mediated growth suppression in the Lewis lung carcinoma cell lines.
    Takemoto N; Serada S; Fujimoto M; Honda H; Ohkawara T; Takahashi T; Nomura S; Inohara H; Naka T
    Oncotarget; 2015 May; 6(13):11009-22. PubMed ID: 25826092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardamonin Inhibits Metastasis of Lewis Lung Carcinoma Cells by Decreasing mTOR Activity.
    Niu PG; Zhang YX; Shi DH; Liu Y; Chen YY; Deng J
    PLoS One; 2015; 10(5):e0127778. PubMed ID: 25996501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The potential role of Id1 in COX-2 mediated angiogenesis in gastric cancer].
    Lei T; Han S; Guo XY; Ding R; Li Y; Xie HH; Bai FH; Wu KC; Ding J
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1570-5. PubMed ID: 17785115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth.
    Standiford TJ; Kuick R; Bhan U; Chen J; Newstead M; Keshamouni VG
    Oncogene; 2011 May; 30(21):2475-84. PubMed ID: 21278795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice.
    Barbarin V; Arras M; Misson P; Delos M; McGarry B; Phan SH; Lison D; Huaux F
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):78-85. PubMed ID: 14975940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
    Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
    Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.